![Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies](https://www.g2intelligence.com/wp-content/uploads/2023/02/Feb1-2023.News_.AI-Breast-Biopsy-iStock-1800x1250-1-1080x675.jpg)
Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies
While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.
While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Key Dx announcements last week involved companion diagnostics, liquid biopsy assays, and an RUO leukemia test.
DNA sequencing technologies may revolutionize the early detection and prevention of the disease.
Deals involving the development and commercialization of new cancer diagnostics and treatments were the most common in December.